AMYLIN PHARMACEUTICALS INC: capex

Value{"amount": 295060000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2008-01-01 – 2008-12-31
Statuscurrent
EntityAMYLIN PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001047469-11-001418 · Open the official SEC filing →
Retrieved: 2026-08-19T08:48:00.440667+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000881464/capex/2008-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/cf417416-c1d6-43fa-a48f-efd4bba009c0

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies